Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
20 /100
LOW RISK
Score updated Aug 28, 2026

TMDX — TransMedics Group, Inc. Dilution Risk Tracker

Track TMDX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TMDX — Get alerts when the score changes →

As of August 28, 2026, TransMedics Group, Inc. (TMDX) has a DilutionWatch DilutionScore of 20/100, rated LOW dilution risk. TransMedics Group, Inc. has a market capitalization of $2.32B, 34.68M shares outstanding, 425 institutional holders tracked. Stored dilution-related fields include 14.4K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 19% potential dilution
• Elevated convertible risk (60/100)
🔔 Track TMDX — Get forecast alerts →

Market Data

Market Cap$2.32B
Shares Outstanding34.68M
Float33.45M
Cash$357.79M
Debt$78.80M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.0% shares (2026Q1 vs prior)
425 institutional holders · 43.71M shares
#1 BlackRock, Inc. 5.29M shares
#2 FMR LLC 5.10M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.96M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.67M
Days to Cover9.5
% of Float22.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-12-31
xbrl XBRL WARRANT 2024-04-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual TMDX Dilution Snapshot

TransMedics Group, Inc. (TMDX) has a DilutionScore of 20/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track TMDX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TMDX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TMDX
TMDX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.